Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tolnaftate adverse reaction |
Causative agent (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to tolnaftate (finding) |
Causative agent (attribute) |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate 10 mg/g cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzalkonium chloride and tolnaftate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzalkonium- and tolnaftate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing chlorhexidine and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to tolnaftate (finding) |
Causative agent (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing tolnaftate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate 10 mg/g cutaneous powder |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolnaftate 10 mg/g cutaneous powder |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has basis of strength substance (attribute) |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has precise active ingredient |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
False |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tolnaftate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzalkonium and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing chlorhexidine and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing nystatin and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorhexidine and tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzalkonium and tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nystatin and tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzalkonium and tolnaftate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only chlorhexidine and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only nystatin and tolnaftate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tolnaftate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has precise active ingredient |
True |
Tolnaftate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |